Last reviewed · How we verify
Spirulina
At a glance
| Generic name | Spirulina |
|---|---|
| Sponsor | Tanta University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
- Spirulina Platensis Supplementation and Calorie Restriction in Obese Men : A Randomized Controlled Trial Protocol Study (NA)
- LMN-201 for Prevention of C. Difficile Infection Recurrence (PHASE2, PHASE3)
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- Spirulina Derivative for Radiation Esophagitis (PHASE2)
- Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors (PHASE2)
- Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection (PHASE3)
- Evaluation of the Effect of Spirulina-Silicon Supplementation on the Morphological, Biomechanical and Functional Characteristics of the Arterial Wall in the Elderly (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spirulina CI brief — competitive landscape report
- Spirulina updates RSS · CI watch RSS
- Tanta University portfolio CI